JNM (May 2018): Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
JNM (May 2018): Update on 18F-Fluciclovine PET for Prostate Cancer Imaging

JNM (May 2018): Update on 18F-Fluciclovine PET for Prostate Cancer Imaging

JNM, May 2018, Volume 59, Number 5

Member Fee: Free
Non-Member Fee: $15.00

Release Date: May 1, 2018
Expiration Date: May 31, 2021


Authors

Ephraim E. Parent and David M. Schuster

Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia

 

Financial Disclosure

   

 

Name 

Role 

Disclosure 

Ephram E. Parent

Author

Research Grants through: Blue Earth Diagnostics, Ltd.; Emory Winship Comprehensive Cancer Center; Glenn Family Breast Center. Emory University is eligible to receive royalties from 18F-fluciclovine

David M. Schuster

Author 

Research Grants through: Blue Earth Diagnostics, Ltd. and Nihon Medi-Physics Co., Ltd.; Emory Winship Comprehensive Cancer Center; Glenn Family Breast Center. Emory University is eligible to receive royalties from 18F-fluciclovine.

The authors receive support from R01CA129356, R01CA121320, P50CA128301, R01CA204254, R01CA169188, RO1CA156755, R21CA176684, U01CA113913, and R01CA156775.

Todd E. Peterson, PhD 

Chair, Publications Committee 

 

Johannes Czernin, MD 

Editor-In-Chief 

 

Heiko Schoder, MD 

Associate Editor, Continuing Education 

 

Arnold M. Strashun, MD 

Chair, Continuing Education Committee 

 

Norbert Avril, MD

JNM Reviewer 

 

David Groheux, MD

JNM Reviewer 

 

Susan Alexander 

SNMMI Staff, Publications 

 

Caroline Krystek 

SNMMI Staff, Education 

 

 

No Commercial Support was received for this activity 


 

The following members of the Publications Committee have no relevant financial relationships to disclose. 

Danny A. Basso, CNMT, NCT 

Michael M. Graham, PhD, MD 

Heinrich R. Schelbert, MD, PhD 

Henry F. VanBrocklin, PhD 

Paige B. Bennett, MD 

Hossein Jadvar, MD, PhD, MPH, MBA 

Heiko Schoder, MD 

Harvey A. Ziessman, MD 

Johannes Czernin, MD 

Steven M. Larson, MD, FACNM 

Mathew L. Thakur, PhD 

Rebecca Maxey - SNMMI Staff  

Stanley J. Goldsmith, MD 

Rustain L. Morgan, MD 

Kathy S. Thomas, MHA,CNMT,PET 

 


In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the planners and authors have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.  

The JNM editors, reviewers and SNMMI Staff have indicated that they do not have a financial interest, arrangement or affiliation with any commercial organization that may have a direct or indirect interest in the content of manuscripts submitted to JNM. 

 

Target Audience

This article contains information of value to nuclear medicine pharmacists and technologists.


Objectives 

At the completion of this activity, the participant should be able to:

1. Describe clinical indications for fluciclovine PET and accuracy for local and metastatic disease.
2. Discuss fluciclovine PET imaging protocol optimization.
3. Review correct interpretations of local and metastatic disease and benign physiologic variants.


Continuing Education Credit Information

ACPE (Pharmacists)
The Society for Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE. Total available credit for pharmacists is 1.0 hours or 0.10 CEUs. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation. You will have no more than 3 attempts to successfully complete the post-test. ACPE UPN:
0210-0000-18-102-H04-P.

VOICE (Technologists)
The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this journal article for a maximum of 1.0 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A+ credit. In order to receive CE credit, you must first complete the activity content. When completed, take the post-test assessment.  You must obtain a score of 80% to receive the CE credit.  You will have no more than 3 attempts to successfully complete the post-test. California Scope: 1.0 Imaging (I).


Minimum system requirements

Supported Operating Systems: Windows (8/7/Vista/XP) or Mac OS X

Supported Internet Browsers: Windows OS Users:
- Microsoft Internet Explorer (version 8 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)

Supported Internet Browsers: Mac OS X Users:
- Apple Safari (version 4 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)

Internet Browser Settings:
- Pop-Up Blocker should be disabled
- Java Script should be enabled
- Java should be enabled
- Cookies should be enabled

Plug-ins:
- Adobe Flash Player (http://get.adobe.com/flashplayer/)
- Adobe Acrobat Reader (http://get.adobe.com/reader/)

Hardware Requirements:
- Computer:  1 GHz with 500 MB RAM or better
- Internet Connection:  A broadband connection (DSL, Cable, etc.)
- Sound:  Speakers or headset to hear audio
- Display:  A display screen area of 800 x 600 pixels or higher

Policy on Privacy and Confidentiality: http://www.snmmi.org/index.cfm?PageID=926

For questions please contact the Education Department at Education@snmmi.org 703-708-9000.

© 2018 SNMMI. All rights reserved.   


Type:     Internet Activity (Enduring Material)
353 Registered Users